Skip to main content
Caplight Logo









GT Medical Technologies

GT Medical Technologies

Private
Tempe, ArizonaHealthcare & Life Scienceshttps://gammatile.com/

Last Round

Series E

Jun 9, 2026

Total Funding Raised

$262M

Momentum

Top 10%

of companies Caplight tracks

Company Overview

GT Medical Technologies is a medical device company that develops innovative therapeutic solutions, including the FDA-cleared GammaTile Therapy, to improve outcomes for patients with operable brain tumors.

Sector

Healthcare & Life Sciences

Verticals

Medical Devices, Biotechnology

Business Model

B2B

Customer Profile

Hardware Sales

AI Layer

Non-AI

Keywords

brachytherapyradiation therapybrain tumor treatmentmedical deviceradiotherapy implantbioresorbable implantsurgical oncologyneuro-oncologycancer implantlocalized radiationbrain cancer techmedtechsurgical radiationtumor resection

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

GT Medical Technologies Comparables

Compare GT Medical Technologies with similar companies based on industry and business-model similarity.

GT Medical Technologies comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Alpha Tau Medical
76%
Azurity Pharmaceuticals
75%
ZAP Surgical Systems
73%

GT Medical Technologies Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Series EJun 9, 2026
Series DJul 15, 2025
DebtSep 12, 2024
Series CMar 23, 2023
Series BNov 23, 2020
Series A
Feb 1, 2019

Secondary Market Activity

Bids, offers, and trades by month

Data table
OperationDatePriceSizeShare ClassStructure
BID
BID

Key People

Founding team and executive leadership

Per Langoe

Chief Executive Officer

Executive Team

David Brachman

Chief Technology Officer

Executive Team

Ole Mikkelsen

Chief Operating Officer

Executive Team

GT Medical Technologies Investors

Notable investors and investment history

GT Medical Technologies investors
InvestorRounds
Evidity Health CapitalSeries E, Series D
Gilde HealthcareSeries E, Series D, Series C
Medical Technology Venture PartnersSeries E, Series D, Series C, Series B, Series A, Seed
Warren Point CapitalSeries D
Viking Global InvestorsSeries E
Horizon Technology Finance CorporationDebt
BlueStone Venture PartnersSeries A, Series C, Series B

Market signals

Structured signals derived from secondary market and firmographic data.

  • Jun 9, 2026

    $100M round led by Viking Global Investors

  • Jul 15, 2025

    $53M round completed.

GT Medical Technologies Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

GT Medical Technologies Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about GT Medical Technologies's valuation, stock price, and market status.

Firmographic Details

HeadquartersTempe, Arizona
Employee Range84
Year Founded2017
Last FundingJun 9, 2026

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?